newsfilter
← Latest News
Business Wire·

Millendo Therapeutics to Present at the Stifel 2019 Healthcare Conference

ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments primarily for orphan endocrine diseases, announced today that Julia C. Owens, Ph.D., President and Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19, 2019 at 9:45 a.m. EST.